What does the Korlym label mean?
Korlym (mifepristone) comes with specific labeling that explains who it is for, how it should be used, and key safety warnings. The label is especially important because Korlym is used in patients with Cushing’s syndrome that cannot be cured with surgery or where surgery isn’t an option, and because mifepristone can cause serious complications.
If you tell me what exact part of the label you mean (for example: “indications,” “dosage,” “boxed warning,” “contraindications,” “pregnancy warning,” or “drug interactions”), I can summarize that specific section in plain language.
For what condition is Korlym approved (label indication)?
Korlym is labeled for treatment of adults with endogenous Cushing’s syndrome with hyperglycemia and/or type 2 diabetes mellitus who cannot be cured by surgery or in whom surgery is not an option.
What are the most important safety warnings on the Korlym label?
Korlym labeling emphasizes several high-risk issues that affect eligibility and monitoring, including:
- Pregnancy risk: mifepristone can cause fetal harm, so Korlym has strict guidance around pregnancy testing and avoidance.
- Adrenal insufficiency effects: because mifepristone blocks cortisol effects, patients may develop adrenal insufficiency and need close monitoring.
- Drug interactions: the label includes interaction warnings (for example, medications that strongly affect CYP3A metabolism can change mifepristone exposure).
How is Korlym dosed according to the label?
The Korlym label provides dosing steps and a titration approach based on response and tolerability, along with instructions on dose adjustments and monitoring.
If you want, share the label dose range you’re looking at (for example, the starting dose or titration interval) and I’ll restate it clearly.
What does the Korlym label say about monitoring labs and follow-up?
The label includes monitoring requirements tied to cortisol blockade and metabolic effects, such as clinical response and glucose-related monitoring for patients with diabetes/hyperglycemia.
What situations mean Korlym is not appropriate (contraindications on the label)?
Korlym’s label lists situations where the drug should not be used, typically involving pregnancy risk and other circumstances that increase harm.
Is Korlym the same as other mifepristone products?
Korlym is a brand of mifepristone with labeling specific to Cushing’s syndrome. Mifepristone is also used in other contexts with different labeling, dosing, and safety guidance.
---
Quick check so I can answer precisely
When you say “Korlym label,” do you mean:
1) the approved indication,
2) the boxed/pregnancy warning,
3) dosing/titration instructions, or
4) a specific warning/contraindication line you’re looking at?
Reply with the exact section name or paste the sentence you want explained.